StockData
Aktis Oncology, Inc. logo

Aktis Oncology, Inc. (AKTS) stock

AKTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$16.31+0.15 (+0.93%)

Close on Nov 17, 2026Market cap $907.15MP/E –Yield –

Aktis Oncology price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Aktis Oncology's price to book ratio was 1.9× on Nov 11, 2026.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.9×–

More Aktis Oncology figures

See a number that looks wrong?